Skip to Main Content

Paper Details

Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.
Nat Commun
45
2019
CDK2, EWSR1, EwS, EwS cells, Ewing sarcoma, FLI1, MYBL2, Pediatric malignancies, cancer, dominant oncogenes, germline, patient, polymorphic enhancer-like DNA element, regulatory genome, regulatory germline variants, transcription factor MYBL2, tumor
Author NameAffiliation
Florencia Cidre-AranazInstitute of Pathology
Didier SurdezINSERM U, PSL Research University, Institut Curie Research Centre
Frank WestermannGerman Cancer Research Center (DKFZ)
Uta DirksenUniversity Hospital of Essen
Uta DirksenUniversity Hospital of Essen
Barak RotblatBen-Gurion University of the Negev
Olivier DelattreINSERM U, PSL Research University, Institut Curie Research Centre
Thomas G P Gr??newaldInstitute of Pathology
Thomas G P Gr??newaldInstitute of Pathology
Thomas G P Gr??newald
Thomas G P Gr??newaldGerman Cancer Research Center (DKFZ)
  • 1 - 11

Datasets

Release 1.2